Novo Nordisk teams with Langer-founded Vivtex on oral obesity therapies
Novo Nordisk is partnering with Vivtex, a biotech co-founded by MIT’s Robert Langer, to develop oral obesity therapies, expanding the pharmaceutical giant’s push into obesity drugs.